Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.2, 2005-01, pp. : 143-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes: A Systematic Review on Content and Adherence to Guidelines

By Vegter Stefan

PharmacoEconomics, Vol. 26, Iss. 7, 2008-01 ,pp. : 569-587

Adis International

Access to resources Recommend Favorite

Expert Judgement in Pharmacoeconomic Studies: Guidance and Future Use

By Evans C. Crawford B.

PharmacoEconomics, Vol. 17, Iss. 6, 2000-06 ,pp. : 545-553

Adis International

Access to resources Recommend Favorite

Adherence of Pharmacoeconomic Studies to National Guidelines in the Netherlands

By Atthobari Jarir Bos Jasper Boersma Cornelis Brouwers Jacobus Jong-van den Berg Lolkje Postma Maarten

Pharmacy World and Science, Vol. 27, Iss. 5, 2005-10 ,pp. : 364-370

Springer Publishing Company

Access to resources Recommend Favorite

The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis

By Coyle D.

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 357-363

Adis International

Access to resources Recommend Favorite

Systematic review of pharmacoeconomic studies of pharmacogenomic tests

By Beaulieu Mathieu de Denus Simon Lachaine Jean

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1573-1590

Future Medicine

Access to resources Recommend Favorite